Şimdi başlat
ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)

ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)

İşlem yok
Süper-grafiklerde görün
Genel Bakış Finansal Haberler Fikirler Tartışmalar Teknikler Mevsimlik
Tahvil

ABBVD tahvilleri

Aşağıda ABBVIE INC CEDEAR EA 10 REP 1 COM(USD) şirket tahvillerinin listesi bulunmaktadır. Yatırımcılar genellikle piyasa dalgalanması zamanlarında artan istikrarları için bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol
Vade sonu getirisi %
Hacim
Fiyat %
Kupon %
Vade Tarihi
Ödenmemiş tutar
Nominal değer
Asgari brm tutarı
İhraççı
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
8,05%30 K75,00%4,63%2042-10-0167,49 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7,40%15 K79,63%4,85%2044-06-1565,23 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,28%10 K79,20%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AA5QDALLERGAN FNDG 15/25
7,16%099,40%3,80%2025-03-15130,22 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
6,26%15,2 M80,44%4,25%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
6,19%083,97%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
6,15%619 K85,14%4,40%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
6,10%087,25%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
6,08%800 K87,57%4,63%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
6,05%181 K88,19%4,75%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
6,04%150 K88,60%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
6,01%300 K89,62%4,85%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
6,00%9,04 M94,11%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,89%9,82 M94,69%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,87%646 K85,56%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,78%2,25 M96,09%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,69%090,40%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,67%150 K92,75%4,55%2035-03-15107,65 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
US287YAR0ABBVIE 15/35
5,60%092,82%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,56%1,67 M93,41%4,55%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5,39%6,26 M97,91%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,10%20 K92,50%3,20%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
5,09%9,52 M92,61%3,20%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
5,03%20,47 M99,63%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,93%099,55%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,90%16,6 M99,66%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,76%2,01 M98,35%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,66%416 K99,85%3,80%2025-03-152,89 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,58%098,25%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,57%11,66 M97,21%2,95%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,56%1,39 M100,48%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
4,08%092,70%2,13%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
XS190919331ALLERGAN FNDG 18/28
4,04%095,27%2,63%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3,86%096,53%2,95%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
3,20%089,03%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3,01%0102,15%3,80%2025-03-151,27 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2,98%097,04%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,95%096,77%2,13%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,92%098,98%2,63%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2,90%0121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2,88%0126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,83%0128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABEABBVIE 19/27
2,78%094,63%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,35%0123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3,80%2025-03-15—1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.